Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
TECARTUS™ Discovered for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Kite discovered Tecartus™ (brexucabtageneautoleucel, formerly KTE-X19), a novel Chimeric Antigen Receptor (CAR) T for the treatment of adult patients with relapsed or refractory Mantle Cell Lymphoma (MCL)....
CTP-543 Novel Therapy Introduced for the Treatment of Alopecia Areata
Concert Pharmaceuticals, Inc introduces CTP-543, Oral Janus kinase inhibitor for the treatment of moderate-to-severe alopecia areata in adult patients....
Talaris Therapeutics Develops Novel Cell Therapy FCR001 for the Treatment of Scleroderma
Novel cell therapy FCR001, was developed by Talaris for the treatment of patients with diffuse systemic sclerosis (SSc), a severe form of the rare autoimmune disease scleroderma....
A Breakthrough Therapy Developed for Investigational Prenatal Treatment ER-004 a Rare Genetic Condition
ER-004, a breakthrough therapy for the prenatal treatment of XLHED, a life-threatening rare genetic condition was developed by EspeRare....
Gvoke HypoPen™ First Autoinjector Discovered for Severe Hypoglycemia
Xeris Pharmaceuticals, Inc discovered novel Gvoke HypoPen™ (glucagon injection),which is used for the treatment of severe hypoglycemia in adults and children with diabetes ages 2 years and above....
GIMOTI™, Novel Nasal Spray Developed for Treatment of Gastroparesisin Adults
GIMOTI™ (metoclopramide), novel nasal spray developed by Evoke Pharma, Inc specifically for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis....
Crysvita - A Breakthrough Therapy Developed For Treatment of TumorInduced Osteomalacia TIO
Crysvita (burosumab-twza) injection the first therapy discovered for the treatment of patients with rare disease, tumor-induced osteomalacia (TIO) corresponding to the age two and older....
Eli Lilly and Company Launched New Rapid Acting Insulin Lyumjev™
Lyumjev™, a new and innovative rapid acting insulin ranging from 100 units/mL and 200 units/mL was launched by Eli Lilly and Company to enhance glycemic control in diabetic patients of type 1 & 2....
A Novel Oral Therapy Discovered to Treat Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Insmed has made a significant discovery in the field of medical treatment by introducing Brensocatib, a breakthrough therapy for adult patients suffering from Non-cystic Fibrosis Bronchiectasis (NCFBE), aimed at reducing exacerbations....
Retevmo™, The First Therapy Developed for Patients with Advanced RET-Driven Lung and Thyroid Cancers
Eli Lilly and Company discovered Retevmo™ (selpercatinib, 40 mg & 80 mg capsules) to treat patients with different types of cancers such as non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer....
